Takeda Annual Profit Rises As Revenue Grows
TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TKPHF.PK) Thursday said profit before tax for the fiscal year 2022 increased to…
26,198$
-0,77%
Echtzeit-Aktienkurs Takeda Pharmaceutical Co. Ltd.
Bid:
Ask:
Nachrichten zur Takeda Pharmaceutical Co. Ltd. Aktie
Takeda FY22 sales grow but FY23 outlook weighed down by generic impact
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K TAKEDA PHARMACEUTICAL For: May 11
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Takeda Pharmaceutical Posted Sharp Fiscal-Year Net Profit Increase -- Earnings Review
Takeda Pharmaceutical Posted Sharp Fiscal-Year Net Profit Increase -- Earnings Review...…
Takeda Pharmaceutical Non-GAAP EPS of ¥558.00, revenue of ¥4.03B; initiates FY23 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Takeda Pharmaceutical 4Q Rev Y960.00B, Given Y3.07T Rev in Preceding 9 Mos, WSJ Calculation Shows>4502.TO
Takeda Pharmaceutical 4Q Rev Y960.00B, Given Y3.07T Rev in Preceding 9 Mos, WSJ Calculation Shows>4502.TO...…
Takeda Pharmaceutical Expected to Post Fourth-Quarter Net Profit -- Earnings Preview
Takeda Pharmaceutical Expected to Post Fourth-Quarter Net Profit -- Earnings Preview...…
Masa Takeda on BOJ and Economic Outlook (Radio)
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology Annual Meeting
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID) reports that Takeda Pharmaceuticals presented…
PAHO in early talks with Takeda over dengue vaccine prices
...(Reuters) - The Pan American Health Organization (PAHO......…
UPDATE 1-PAHO in early talks with Takeda over dengue vaccine prices
... (Reuters) - The Pan American Health
Organization (PAHO) is in preliminary......…
Takeda, Canadian Blood Services ink pact for immunodeficiency disease drugs
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
Collaboration will cover existing and future programs to aid in the development and commercialization of investigational medicines for hematologic malignancies…
Takeda not confirming sale of plant in Russia — source
The Kommersant news outlet reported earlier that Takeda is considering options of selling its Russian plant located in Yaroslavl...…
Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth
Schaefer Comes to Kyowa Kirin from Takeda where he served as Senior Vice President, Neuroscience Business Unit and Head of…
Takeda: HYQVIA Gets FDA Approval To Treat Primary Immunodeficiency In Children
TOKYO (dpa-AFX) - Japans Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Tuesday that the U.S. Food and Drug Administration has…
Centogene stock surges ~15% on extending diagnostic pact with Takeda
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Centogene Extends Genetic Testing Partnership With Takeda
Centogene Extends Genetic Testing Partnership With Takeda...…
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential…
Innate Pharma Grants Takeda Exclusive Rights To Antibody Drug Conjugates; Stock Rises
PARIS (dpa-AFX) - Shares of Innate Pharma SA (IPHA) were gaining around 14 percent in the morning trading in Paris…
Innate Pharma Shares Rise 14% After Licensing Deal With Takeda
Innate Pharma Shares Rise 14% After Licensing Deal With Takeda...…
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
Takeda gibt Kandidaten für die Wahl in das Board of Directors bei der kommenden Aktionärsversammlung bekannt
OSAKA, Japan--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) gab bekannt, dass das Board of Directors heute beschlossen hat, auf der 147. ordentlichen Hauptversammlung der…
Form 6-K TAKEDA PHARMACEUTICAL For: Mar 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Takeda to invest ¥100B for new plasma-derived drugs facility in Japan
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Takeda hits main goals in mid-stage trial for plaque psoriasis therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K TAKEDA PHARMACEUTICAL For: Mar 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Takeda raised to Buy at BofA on growth prospects and debt repayment
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Hutchmed China inks global licensing deal with Takeda on fruquintinib
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., March 14, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited…
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
Japanese pharmaceutical firm Takeda lowers price of dengue shot in Brazil and Indonesia
The cost for Qdenga in Indonesia will be about one-third its European price, far lower than many other innovative vaccines,…
Takeda Offers Dengue Shot Cheaper in Brazil, Indonesia
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
HUTCHMED Reports 2022 Full Year Results and Provides Business Updates
Landmark licensing deal with Takeda for fruquintinib outside of China, bringing HUTCHMED up to US$1.13 billion, plus royalties, and demonstrating execution…
Antacids Global Market Report 2023
NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antacids market are GlaxoSmithKline plc, Pfizer Inc., Bayer AG,…
Takeda Entyvio meets main goal in phase 3 trial to prevent intestinal acute graft-versus-host disease
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Antiobesity Global Market Report 2023
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC,…
Form 6-K TAKEDA PHARMACEUTICAL For: Feb 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Takeda schließt Übernahme der TYK2-Programm-Tochter von Nimbus Therapeutics ab
OSAKA, Japan, und CAMBRIDGE, Massachusetts, USA--(BUSINESS WIRE)--Takeda today announced that it has completed an acquisition of all shares of Nimbus…
Amerikanische Arzneimittelbehörde FDA genehmigt TAKHZYRO® (Lanadelumab-flyo) von Takeda zur Verhinderung von Attacken des hereditären Angioödems (HAE) bei Kindern im Alter ab 2 Jahren
OSAKA (Japan) und CAMBRIDGE (Massachusetts, USA)--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) gab heute bekannt, dass die US-amerikanische Arzneimittelzulassungsbehörde (FDA) den ergänzenden Zulassungsantrag für…
Takeda Says FDA Approves Takhzyro to Prevent HAE Attacks in Young Patients
Takeda Says FDA Approves Takhzyro to Prevent HAE Attacks in Young Patients...…
Takeda stärkt langfristiges Wachstum durch Fortschritte in der Pipeline und zwei gezielte Akquisitionen; erneut ein starkes drittes Quartal im GJ2022
OSAKA, Japan--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) gab heute die Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2022 (Zeitraum bis 31. Dezember 2022)…
Takeda Pharma 9-month Net Profit Increases
TOKYO (dpa-AFX) - Japans Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) reported that its net profit for the nine-month period ended…
Takeda Pharmaceutical Non-GAAP EPS of ¥456.00, revenue of ¥3071.3B; reaffirms full-year guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Takeda Pharmaceutical 9-Mos EPS Y184.32 Vs EPS Y154.09
Takeda Pharmaceutical 9-Mos EPS Y184.32 Vs EPS Y154.09...…
Takeda Pharmaceutical Third-Quarter Net Profit Rose Sharply
Takeda Pharmaceutical Third-Quarter Net Profit Rose Sharply...…
Takeda Pharmaceutical Q3 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
HUTCHMED Swells 11% by Midday; G Sachs Sees License Agreement with Takeda as Significant Progress
HUTCHMED (00013.HK) further expanded its upswing after opening high by 5.6% today (26th). Once peaking at $30.8, the stock closed…
Insights on the Insomnia Global Market to 2028 - Featuring Eisai, Takeda Pharmaceutical, Vanda Pharmaceuticals and Cadila Healthcare Among Others
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel,…
Takeda inks deal with Hutchmed for up to $1.1 billion
Takeda Pharmaceutical Co. Ltd. TAKJP:4502 said Monday that it will acquire Hutchmed’s HCMHK:13 experimental cancer treatment outside mainland China, Hong…